Findings from the stratified analyses suggest that the increased risk of PCa overall among taller men may be due to higher uptake of PSA testing (increased low-risk disease), while the inverse association with BMI may be due to lower uptake of PSA testing (i.e., detection bias). The gene discussed is KLK3; the disease is posterior cortical atrophy.